# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1032318 | B | Inhibition of CDK1/cyclin B | 27 | protein complex format | Scientific Literature | |||
2. | ALA1032319 | B | Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli | Homo sapiens | 27 | assay format | Scientific Literature | ||
3. | ALA1032320 | B | Inhibition of pig GSK3alpha/beta | Cavia porcellus | 27 | assay format | Scientific Literature | ||
4. | ALA1032324 | A | Cytotoxicity against human SH-SY5Y cells after 48 hrs by MTS reduction assay | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
5. | ALA3270664 | B | Inhibition of human recombinant 5-LO assessed as product formation at 3 uM by cell-free assay relative to control | Homo sapiens | 25 | single protein format | Scientific Literature | ||
6. | ALA3270665 | B | Inhibition of 5-LO in human neutrophils assessed as product formation at 3 uM by cell-intact assay relative to control in presence of 2.5 uM A23187 ionophore | Homo sapiens | 25 | single protein format | Scientific Literature | ||
7. | ALA4042002 | F | Cytotoxicity against human KCL22 cells assessed as cell viability at 1 uM after 48 hrs by MTS assay relative to control | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
8. | ALA4042003 | F | Cytotoxicity against human KCL22 cells harboring ABL1 T315I mutant assessed as cell viability at 1 uM after 48 hrs by MTS assay relative to control | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
9. | ALA4042006 | F | Cytotoxicity against human KCL22 cells assessed as reduction in cell viability after 48 hrs by MTS assay | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
10. | ALA4042007 | F | Cytotoxicity against human KCL22 cells harboring ABL1 T315I mutant assessed as reduction in cell viability after 48 hrs by MTS assay | Homo sapiens | 15 | cell-based format | Scientific Literature |